Dizal (jiangsu) Pharmaceutical Co. Ltd. Class ASSE: 688192

Announcement on Release of Multiple Latest Research Results in the Field of Lung Cancer by the Company at the 2025 World Conference on Lung Cancer (WCLC)

· Issued by Dizal (jiangsu) Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Release of Multiple Latest Research Results in the Field of Lung Cancer by the Company at the 2025 World Conference on Lung Cancer (WCLC)

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis